Search Results

Showing 100 results

• 

  Key Opinion

  Skin Barrier Dysfunction: Clinical Implications Across Dermatologic Conditions (dummy 44)

• 

  Key Opinion

  Skin Barrier Dysfunction: Clinical Implications Across Dermatologic Conditions (dummy 39)

• 

  Key Opinion

  Decoding the Skin Microbiome’s Role (dummy 45)

• 

  Key Opinion

  Proposed prostheses List reforms: What do they mean for ophthalmologists? (dummy 42)

• 

  Key Opinion

  Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist (dummy 43)

• 

  Key Opinion

  Decoding the Skin Microbiome’s Role (dummy 40)

• 

  Key Opinion

  Therapies for diabetic retinopathy: Latest news from the American Diabetes Association (dummy 36)

• 

  Key Opinion

  Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist (dummy 13)

• 

  Key Opinion

  Proposed prostheses List reforms: What do they mean for ophthalmologists? (dummy 12)

• 

  Key Opinion

  Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist (dummy 8)

• 

  Key Opinion

  Therapies for diabetic retinopathy: Latest news from the American Diabetes Association (dummy 11)

• 

  Key Opinion

  Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist (dummy 3)